Fibroblast growth factor-8b-stimulated myogenic cell proliferation is suppressed by the promyelocytic leukemia gene

NeuroSignals

Volumn 10, Issue 5, 2001, Pages 285-293

  Kwong, W H ^a   Tang, M K ^a   Yew, D T ^a   Chan, J Y H ^a   Cai, D Q ^a   Tong, W M ^a   Lee, K K H ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

FGF 8b; G8 myogenic cells; PMLgene; Signal transduction

Indexed keywords

FIBROBLAST GROWTH FACTOR 8; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; FETUS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; ONCOGENE C FOS; ONCOGENE C MYC; PROMYELOCYTIC LEUKEMIA; SIGNAL TRANSDUCTION; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

ANIMALS; BLOOD PHYSIOLOGY; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTORS; GENES, REPORTER; GENES, SYNTHETIC; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; MICE; MUSCLE, SKELETAL; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; SIGNAL TRANSDUCTION; STRESS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0034887329     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000046895     Document Type: Article

References (32)

1. Clegg CH, Linkhart TA, Olwin BB, Hauschka SD: Growth factor control of skeletal muscle differentiation: Commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J Cell Biol 1987;105:949-956.
2. Jin PT, Sejersen T, Ringertz NR: Recombinant platelet-derived growth factor-BB stimulates growth and inhibits differentiation of rat L6 myoblasts. J Biol Chem 1991;266: 1245-1249.
3. Reynaud EG, Pelpel K, Guillier M, Leibovitch MP, Leibovitch SA: p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts. Mol Cell Biol 1999;19:7621-7629.
4. Webb SE, Lee KKH, Tang MK, Ede DA: Fibroblast growth factors 2 and 4 stimulate migration of mouse embryonic limb myogenic cells. Dev Dyn 1997;209:206-216.
5. Webb SE, Lee KKH: Effect of platelet-derived growth factor isoforms on the migration of mouse embryo limb myogenic cells. Int J Dev Biol 1997;41:597-605.
6. Keller HL, St Pierre Schneider B, Eppihimer LA, Cannon JG: Association of IGFI-and IGF-II with myofiber regeneration in vivo. Muscle Nerve 1999;22:347-354.
7. Sheehan SM, Allen RE: Skeletal 0muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepa-tocyte growth factor. J Cell Physiol 1999;18:499-506.
8. Goldfarb M: Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev 1996;7:311-325.
9. Olwin BB, Hauschka SD: Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture. J Cell Biol 1988; 107:761-769.
10. Weyman CM, Wolfman A: Mitogen-activated protein kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2. Endocrinology 1998;139:1794-1800.
11. Floss T, Arnold HH, Braun T: A role for FGF-6 in skeletal muscle regeneration. Genes Dev 1997; 11:2040-2051.
12. Crossley PH, Martin GR: The mouse FGF-8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 1995; 121:439-451.
13. Lewandoski M, Meyers EN, Martin GR: Analysis of Fgf8 gene function in vertebrate development (review). Cold Spring Harb Symp Quant Biol 1997;62:159-168.
14. Hannon K, Kudla AJ, McAvoy MJ, Clase KL, Olwin BB: Differentially expressed fibroblast growth factors regulate skeletal muscle development through autocrine and paracrine mechanisms. J Cell Biol 1996; 132:1151-1159.
15. MacArthur CA, Lawshe A, Xu J, Santos-Ocampo S, Heikinheimo M, Chellaiah AT, Ornitz DM: FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse development. Development 1995; 121: 3603-3613.
16. Tanaka A, Miyamoto K, Minamino N, Takeda M, Sato B, Matsuo H, Matsumoto K: Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc Natl Acad Sci USA 1992;89:8928-8932.
17. Tanaka A, Miyamoto K, Matsuo H, Matsumoto K, Yoshida H: Human androgen-induced growth factor in prostate and breast cancer cells: Its molecular cloning and growth properties. FEBS Lett 1995;363:226-230.
18. Tanaka A, Furuya A, Yamasaki M, Hanai N, Kuriki K, Kamiakito T, Kobayashi Y, Yoshida H, Koike M, Fukayama M: High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohisto-chemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8. Cancer Res 1998;58:2053-2056.
19. Mu ZM, Le XF, Vallian S, Glass-man AB, Chang KS: Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis 1997; 18:2063-2069.
20. Le XF, Vallian S, Mu ZM, Hung MC, Chang KS: Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 1998;16:1839-1849.
21. Koken MH, Reid A, Quignon F, Chelbi-Alix MK, Davies JM, Kaba-rowski JH, Zhu J, Dong S, Chen S, Chen Z, Tan CC, Licht J, Waxman S, dethe H, Zelent A: Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc Natl Acad Sci USA 1997;94:10255-10260.
22. Tian XX, Chan JY, Pang JC, Chen J, He JH, To TS, Leung SF, Ng HK: Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-recep-tor. Br J Cancer 1999;81:994-1001.
23. Chan JYH, Li L, Fan YH, Mu ZM, Zhang WW, Chang KS: Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML. Biochem Biophys Res Com-mun 1997;240:640-646.
24. Heikkila R, Schwab G, Wickstrom E, Loke S, Pluznik D, Watt R, Neck-ers L: A c-myc antisense oligodeoxy-nucleotide inhibits entry into S phase but not progress from G0 to G1. Nature 1987;328:445-449.
25. Eilers M, Picard D, Yamamoto KR, Bishop JM: Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 1989;340:66-68.
26. Roussel MF, Theodoras AM, Paga-no M, Sherr CJ: Rescue of defective mitogenic signaling by D-type cy-clins. Proc Natl Acad Sci USA 1995; 92:6837-6841.
27. Kudla AJ, John ML, Bowen-Pope DF, Rainish B, Olwin BB: A requirement for fibroblast growth factor in regulation of skeletal muscle growth and differentiation cannot be replaced by activation of platelet-derived growth factor signaling pathways. Mol Cell Biol 1995; 15: 3238-3246.
28. Chalaux E, Lopez-Rovira T, Rosa JL, Bartrons R, Ventura F: JunB is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2. J Biol Chem 1998;273:537-543.
29. Aurade F, Pfarr CM, Lindon C, Garcia A, Primig M, Montarras D, Pinset C: The glucocorticoid receptor and AP-1 are involved in a positive regulation of the muscle regulatory gene myf5 in cultured myoblasts. J Cell Sci 1997;110:2771-2779.
30. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, Grosveld F, Pandlfi PP: Role of PML in cell growth and the retinoic acid pathway. Science 1998;279: 1547-1551.
31. Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R, Pandol-fi PP: PML is essential for multiple apoptotic pathways. Nat Genet 1998;20:266-272.
32. Le XF, Yang P, Chang KS: Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J Biol Chem 1996;271:130-135